The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
First-in-human dose escalation study of oral ONC201 in advanced solid tumors.
 
Mark N. Stein
No Relationships to Disclose
 
Tina M. Mayer
No Relationships to Disclose
 
Rebecca Anne Moss
No Relationships to Disclose
 
Ann W. Silk
No Relationships to Disclose
 
Nancy Chan
No Relationships to Disclose
 
Bruce George Haffty
No Relationships to Disclose
 
Robert S. DiPaola
No Relationships to Disclose
 
Yasmeen Beckett
No Relationships to Disclose
 
Edward Bentlyewski
No Relationships to Disclose
 
Ling Zheng
No Relationships to Disclose
 
Bruno Fang
No Relationships to Disclose
 
Joshua Allen
Employment - Oncoceutics
Leadership - Oncoceutics
Stock and Other Ownership Interests - Oncoceutics
Patents, Royalties, Other Intellectual Property - Oncoceutics
 
Janice M. Mehnert
Consulting or Advisory Role - Amgen/Dompé (Inst)
Research Funding - Merck (Inst); Merck (Inst); Merck (Inst); Novartis (Inst); polynoma (Inst); Sanofi (Inst)
Other Relationship - Amgen